Pharmaids Pharmaceuticals Ltd (PHARMAID) is currently trading at 30.21 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Pharmaids Pharmaceuticals Limited, established in Hyderabad, is a supplier of quality-grade speciality chemicals, skin care, hospital care, and generic pharmaceutical products covering orthopedic, neuro, and gastro areas. The company is involved in manufacturing generics and bulk drugs in diverse forms, including tablets, capsules, liquids, and powders across allopathic, Ayurvedic, and herbal formulations. Significantly, Pharmaids Pharmaceuticals completed the amalgamation of Emergent Bio Naturals Limited in 2019, leading to the issuance of over 6.9 million shares to Emergent's shareholders. Pharmaids Pharmaceuticals acquired a 25.5% stake in Anugraha Chemicals in February 2023, expanding its business interests into partnerships with specialized chemical firms. The company's specialized expertise in both allopathic and natural drug formulations positions it uniquely in the competitive pharmaceutical landscape.

Over the past 52 weeks, Pharmaids Pharmaceuticals Ltd has traded between a low of ₹25.60 and a high of ₹66.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Pharmaids Pharmaceuticals Ltd has a market capitalization of approximately 106.30. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Pharmaids Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -24.21 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 106.30 Cr, Pharmaids Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Pharmaids Pharmaceuticals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Pharmaids Pharmaceuticals Ltd is -24.21. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.